Interleukin-1RN gene polymorphisms in elderly patients with rheumatic inflammatory chronic conditions: Association of IL-1RN*2/2 genotype with polymyalgia rheumatica.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[2]  J. Pérez-López,et al.  Arteritis de células gigantes , 2006 .

[3]  R. Caporali,et al.  Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[4]  I. Olivieri,et al.  Inflammatory changes of hip synovial structures in polymyalgia rheumatica. , 2005, Clinical and experimental rheumatology.

[5]  C. Dinarello.  Blocking IL-1 in systemic inflammation , 2005, The Journal of experimental medicine.

[6]  Ricardo Blanco,et al.  HLA-DRB1 allele distribution in polymyalgia rheumatica and giant cell arteritis: influence on clinical subgroups and prognosis. , 2004, Seminars in arthritis and rheumatism.

[7]  M. López-Hoyos,et al.  Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. , 2004, Rheumatology.

[8]  D. Heijde,et al.  Development and preselection of criteria for short term improvement after anti-TNFα treatment in ankylosing spondylitis , 2004, Annals of the rheumatic diseases.

[9]  D. Colomer,et al.  Tissue production of pro-inflammatory cytokines (IL-1beta, TNFalpha and IL-6) correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. , 2003, Rheumatology.

[10]  Dolors Colomer,et al.  Elevated Production of Interleukin-6 Is Associated With a Lower Incidence of Disease-Related Ischemic Events in Patients With Giant-Cell Arteritis: Angiogenic Activity of Interleukin-6 as a Potential Protective Mechanism , 2003, Circulation.

[11]  W. Hop,et al.  Are cytokine gene polymorphisms related to in vitro cytokine production profiles? , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  J. M. C. Romero,et al.  Arteritis de células gigantes , 2002 .

[13]  W. Thomson,et al.  Lack of association between IL-1 cluster and TNF-alpha gene polymorphisms and giant cell arteritis. , 2002, Clinical and experimental rheumatology.

[14]  R. Straub,et al.  Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. , 2002, The Journal of rheumatology.

[15]  J. Fernandez-Solà,et al.  A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant-cell arteritis. , 2002, Arthritis and rheumatism.

[16]  K. Tschöp,et al.  Influence of the IL‐1Ra gene polymorphism on in vivo synthesis of IL‐1Ra and IL‐1β after live yellow fever vaccination , 2001, Clinical and experimental immunology.

[17]  I. Olivieri,et al.  Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. , 2001, The Journal of rheumatology.

[18]  W. Arend,et al.  Biological role of interleukin 1 receptor antagonist isoforms , 2000, Annals of the rheumatic diseases.

[19]  Y. Shoenfeld,et al.  The relationship of antiphospholipid antibodies to infections--do they bind to infecting agents or may they even be induced by them? , 2000, Clinical and experimental rheumatology.

[20]  J. Schölmerich,et al.  The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica. , 2000, Rheumatology.

[21]  J. Schölmerich,et al.  Favorable role of interleukin 10 in patients with polymyalgia rheumatica. , 1999, Journal of Rheumatology.

[22]  A. Stanson,et al.  Disease pattern in cranial and large-vessel giant cell arteritis. , 1999, Arthritis and rheumatism.

[23]  M. Hurme,et al.  IL‐1 receptor antagonist (IL‐1Ra) plasma levels are co‐ordinately regulated by both IL‐1Ra and IL‐1β genes , 1998 .

[24]  B. Hazleman,et al.  Circulating levels of IL-1beta, IL-6 and soluble IL-2 receptor in polymyalgia rheumatica and giant cell arteritis and rheumatoid arthritis. , 1998, British journal of rheumatology.

[25]  S. Rantapää-Dahlqvist,et al.  Cytokines and adhesion molecules in patients with polymyalgia rheumatica. , 1998, British journal of rheumatology.

[26]  Santtila,et al.  Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro , 1998, Scandinavian journal of immunology.

[27]  G. Panayi,et al.  The sequential analysis of T lymphocyte subsets and interleukin-6 in polymyalgia rheumatica patients as predictors of disease remission and steroid withdrawal. , 1997, British journal of rheumatology.

[28]  V. Rodríguez-Valverde,et al.  Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. , 1997, The American journal of medicine.

[29]  V. Rodríguez-Valverde,et al.  Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. , 1997, Archives of internal medicine.

[30]  C. Weyand,et al.  Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. , 1996, The Journal of clinical investigation.

[31]  G. Hunder,et al.  The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes. , 1996, The Journal of rheumatology.

[32]  H. Gascan,et al.  Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticotherapy. , 1996, The Journal of rheumatology.

[33]  G. Hunder,et al.  Polymyalgia rheumatica and giant-cell arteritis. , 1995, The New England journal of medicine.

[34]  D. Grennan,et al.  Cytokine production by normal human monocytes: inter‐subject variation and relationship to an IL‐1 receptor antagonist (IL‐1Ra) gene polymorphism , 1995, Clinical and experimental immunology.

[35]  G. Hunder,et al.  Tissue Cytokine Patterns in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis , 1994, Annals of Internal Medicine.

[36]  J. Goronzy,et al.  Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. , 1994, The Journal of clinical investigation.

[37]  J. Gauldie,et al.  The acute phase response. , 1994, Immunology today.

[38]  G. Hunder,et al.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. , 1993, Arthritis and rheumatism.

[39]  A. Blakemore,et al.  Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat , 1993, Human Genetics.

[40]  S. Chevalier,et al.  High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL‐6 under corticosteroid therapy , 1993, Clinical and experimental immunology.

[41]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[42]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[43]  G. Hunder,et al.  Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. , 1982, Annals of internal medicine.

[44]  G. Hunder,et al.  Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. , 1978, Annals of internal medicine.

[45]  C. Salvarani,et al.  Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. , 2000, Clinical and experimental rheumatology.

[46]  M. Hurme,et al.  IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. , 1998, European journal of immunology.

[47]  A. Brack,et al.  Disease patterns and tissue cytokine profiles in giant cell arteritis. , 1997, Arthritis and rheumatism.

[48]  A. Portier,et al.  Production of interleukin 6 by granulomas of giant cell arteritis. , 1994, Human immunology.